Impact and Cost of a Pharmacist Pneumococcal Vaccination Program With PNEUMOVAX® 23 at an Urban Senior Center (PPVP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01944462|
Recruitment Status : Completed
First Posted : September 17, 2013
Results First Posted : January 3, 2018
Last Update Posted : January 3, 2018
The overall goals of this program are to measure the impact of a pharmacist pneumococcal vaccine education program (PPVP) using a senior center model of care and provide the pneumococcal vaccine to eligible participants.
- PPVP will result in improved knowledge and awareness in older minorities in the senior center setting (primary hypothesis);
- Participants who are vaccinated through the project will experienced increased trust in receiving vaccines from a pharmacist;
- Participants will be satisfied with and trust the PV information provided by pharmacists in the PPVP;
- PPVP is an efficient approach to educating patients in the senior center based on its costs;
- Participating pharmacists will be activated to implement PPVP learnings in their practice.
|Condition or disease||Intervention/treatment||Phase|
|Study is Open to Seniors Age 50 or Older||Behavioral: Pharmacist Pneumococcal Vaccine Program (PPVP)||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||203 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Impact and Cost of a Pharmacist Pneumococcal Vaccination Program With PNEUMOVAX® 23 at an Urban Senior Center for Adults Aged 65 Years or Older or Those With Defined Risk Factors for Invasive Pneumococcal Disease|
|Study Start Date :||January 2014|
|Actual Primary Completion Date :||November 2014|
|Actual Study Completion Date :||November 2014|
Experimental: Pharmacist Pneumococcal Vaccine Program (PPVP)
Individuals receiving the PPVP intervention which consists of the educational program delivered on site at the collaborating senior center.
Behavioral: Pharmacist Pneumococcal Vaccine Program (PPVP)
1.5 hour educational intervention delivered onsite at collaborating senior center consisting of 3 components: presentation about pneumococcal disease and the vaccine given by a infectious disease-certified pharmacist; 2) skits given by volunteer actors at the senior center to illustrate real world scenarios related to pneumococcal disease and the vaccine; 3) action planning to consist of small group breakouts led by licensed pharmacists and 4) vaccination day which is an optional component following the education program, for participants eligible to receive the vaccine. Vaccination to be provided free of charge to eligible participants who opt to receive it.
- Knowledge and Awareness of Pneumococcal Disease [ Time Frame: Baseline, post-test, 3 months ]Change in knowledge and awareness of pneumococcal disease over time were assessed for the following domains: susceptibility to infection, symptoms of disease, severity of illness, and vaccination with an emphasis on vaccine efficacy, safety, and eligibility. Assessments at baseline, post-test (immediately following intervention), and 3 months using the Pneumonia Knowledge Questionnaire, an instrument developed by investigators to assess participants' knowledge and awareness in the domains of interest. Instrument consists of 5 "mark all that apply" items and one "mark the best response" item. Scores range from 0 (no correct responses) to 28 (all responses correct), with a higher score value corresponding to better knowledge and awareness.
- Trust in Pharmacists as Vaccine Providers [ Time Frame: Baseline, post-test (immediately following intervention), 3 months ]Trust in pharmacists as vaccine providers were measured by comparing responses to the trust items in the baseline, post-test (immediately following intervention), and 3-month assessments. Trust items were coded on a 4-level Likert scale, with lower values corresponding to higher agreement with the trust statements (therefore a lower mean response indicates greater trust). Minimum possible score was 1 (indicating complete trust in pharmacists as vaccine providers) and maximum possible score was 4 (indicating complete lack of trust in pharmacists as vaccine providers).
- Activation [ Time Frame: 3 months ]Activation was measured as number of participants having taken action at 3 months or planning action at baseline, post-test, and 3 months.
- Satisfaction With PPPP [ Time Frame: 3 months ]Satisfaction with PPPP was measured as participants' overall satisfaction with the content of PPPP, extent to which the participant felt engaged, and belief that the program helped them learn about pneumonia and the vaccination.
- Intervention Cost [ Time Frame: 3 months ]Measures PPPP intervention costs per participant. Consists of total program costs divided by number of participants. Value reported is the per-participant cost with measure type "number".
- Pharmacist Satisfaction [ Time Frame: 3 months ]Pharmacists who participated in the intervention were surveyed to determine their satisfaction with the program, including: 1) satisfaction with live action skit, 2) belief that PPPP was successful in educating participants, 3) belief that PPPP was successful in building trust in pharmacists among participants, 4) belief that PPPP was successful in increasing acceptance of pharmacists as immunizers, and 5) belief that PPPP will decrease barriers to vaccination among participants.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01944462
|United States, Pennsylvania|
|Center in the Park|
|Philadelphia, Pennsylvania, United States, 19144|
|Principal Investigator:||Laura Pizzi, PharmD, MPH||Thomas Jefferson University|